European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-24

Active controlled transdermal drug delivery systems

Cel

The proposal aims to develop functional materials and systems to fulfill the need for safe, actively controlled transdermal drug delivery. The effective combination of the partner's skills and resources will develop drug delivery systems to meet several patient centred objectives: e.g.wider use of self administered drugs , at home with a wearable system, more accurate matching of drug dose to drug need, avoiding side effects and long-term complications in chronic diseases (e.g. diabetes and osteoporosis) and improve patient compliance by replacing self injection. This project seeks to extend the scale and range of drugs currently administered non-invasively-e.g. beyond small scale anesthetics and pain killers. The economic impact is to reduce hospitalization, reduce use of PVC consumables and develop a new sector of European health industry .

Słowa kluczowe

Zaproszenie do składania wniosków

Data not available

System finansowania

CSC - Cost-sharing contracts

Koordynator

BAXTER RESEARCH AND DEVELOPMENT EUROPE
Wkład UE
Brak danych
Adres
Rue du Progres 7
1400 NIVELLES
Belgia

Zobacz na mapie

Koszt całkowity
Brak danych

Uczestnicy (5)